Trial Profile
Efficacy and safety of Harvoni (Ledipasvir/Sofosbuvir) in patients with chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 22 Jan 2018 New trial record